<DOC>
	<DOCNO>NCT00471406</DOCNO>
	<brief_summary>Purpose : To investigate efficacy photodynamic therapy verteporfin treatment patient corneal neovascularization . Design : Prospective , non-comparative case series . Participants : Eighteen eye 18 patient stable corneal neovascularization refractory conventional treatment . Methods : The patient treat photodynamic therapy verteporfin ( 6 mg/m2 ) . Five patient treat follow penetrate keratoplasty , 2 patient treat penetrate keratoplasty . Best correct visual acuity anterior segment photography perform treatment . The length cumulative blood vessel area corneal neovascularization measure . Main outcome measure : Vascular occlusion , best correct visual acuity , cumulative blood vessel length , corneal neovascularization area .</brief_summary>
	<brief_title>Photodynamic Therapy With Verteporfin Corneal Neovascularization</brief_title>
	<detailed_description />
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Corneal Neovascularization</mesh_term>
	<mesh_term>Verteporfin</mesh_term>
	<criteria>Patients clinically stable corneal neovascularization improve treatment 1 % prednisolone acetate eyedrop instill 4 time day least 1 month Individuals active keratitis vessel proliferation , uncontrolled inflammation , active hepatitis clinically significant liver disease , porphyria porphyrin sensitivity</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>